BRKR - Bruker - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1167941087

Scientific Instruments, Analytical Solutions, Diagnostic Tools, Microscopy Systems

Bruker Corporation is a leading developer, manufacturer, and distributor of cutting-edge scientific instruments and analytical solutions that cater to a wide range of industries, including life sciences, pharmaceuticals, and materials research. With a strong global presence, the company operates through four key segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

The company's product portfolio is diverse and extensive, featuring life science tools, single and multiple modality systems, and life science mass spectrometry solutions. Its MALDI Biotyper rapid pathogen identification platform and related test kits enable swift and accurate diagnosis of infectious diseases, including COVID-19. Additionally, Bruker offers genotype and fluorotype molecular diagnostics kits, as well as research, analytical, and process analysis instruments and solutions.

Bruker's range of portable analytical and bioanalytical detection systems, X-ray instruments, and analytical tools for electron microscopes enable researchers and scientists to conduct advanced analysis and testing. The company's atomic force microscopy instrumentation, non-contact nanometer resolution solution topography, and automated X-ray metrology solutions provide unparalleled insights into material properties and structures.

Furthermore, Bruker's advanced optical fluorescence microscopy instruments, products, and services support the multi-omics needs of researchers in translational research, drug, and biomarker discovery. The company's superconducting materials, devices, and complex tools based on metallic low temperature superconductors, as well as non-superconducting high technology tools, such as synchrotron and beamline instrumentation, are used in various applications, including materials science and quantum computing.

Founded in 1991, Bruker Corporation is headquartered in Billerica, Massachusetts, and has established itself as a trusted partner for scientists, researchers, and industries worldwide. With a strong commitment to innovation and customer satisfaction, the company continues to push the boundaries of scientific discovery and technological advancement.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for BRKR - Bruker  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for BRKR - Bruker  - Stock Price & Dividends

BRKR Stock Overview

Market Cap in USD 8,858m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 2000-08-04

BRKR Stock Ratings

Growth 5y 18.7
Fundamental 14.5
Dividend 43.1
Rel. Performance vs Sector -1.21
Analysts 4.08/5
Fair Price Momentum 63.89 USD
Fair Price DCF 27.70 USD

BRKR Dividends

Dividend Yield 12m 0.34%
Yield on Cost 5y 0.42%
Dividends CAGR 5y 4.56%
Payout Consistency 96.7%

BRKR Growth Ratios

Growth Correlation 3m -41.2%
Growth Correlation 12m -47.7%
Growth Correlation 5y 52.8%
CAGR 5y 4.98%
CAGR/Mean DD 5y 0.26
Sharpe Ratio 12m 0.21
Alpha vs SP500 12m -32.32
Beta vs SP500 5y weekly 0.98
ValueRay RSI 48.23
Volatility GJR Garch 1y 35.15%
Price / SMA 50 -5.25%
Price / SMA 200 -15.75%
Current Volume 1346.6k
Average Volume 20d 1485.3k

External Links for BRKR Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of BRKR stocks?
As of November 08, 2024, the stock is trading at USD 60.49 with a total of 1,346,625 shares traded.
Over the past week, the price has changed by +6.85%, over one month by -8.28%, over three months by +0.39% and over the past year by +4.12%.
What are the forecast for BRKR stock price target?
According to ValueRays Forecast Model, BRKR Bruker will be worth about 69.9 in November 2025. The stock is currently trading at 60.49. This means that the stock has a potential upside of +15.62%.
Issuer Forecast Upside
Wallstreet Target Price 76.1 25.8
Analysts Target Price 77.8 28.6
ValueRay Target Price 69.9 15.6